{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T22:22:50Z","timestamp":1711146170337},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T00:00:00Z","timestamp":1338249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11239-012-0753-3","type":"journal-article","created":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T09:38:44Z","timestamp":1338197924000},"page":"360-366","source":"Crossref","is-referenced-by-count":9,"title":["Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT"],"prefix":"10.1007","volume":"34","author":[{"given":"Giuseppe","family":"Lippi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,29]]},"reference":[{"key":"753_CR1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","volume":"8","author":"G Lippi","year":"2011","unstructured":"Lippi G, Franchini M, Targher G (2011) Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 8:502\u2013512","journal-title":"Nat Rev Cardiol"},{"key":"753_CR2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0031-1297367","volume":"37","author":"WM Lijfering","year":"2011","unstructured":"Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC (2011) Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost 37:885\u2013896","journal-title":"Semin Thromb Hemost"},{"key":"753_CR3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0029-1145257","volume":"34","author":"G Lippi","year":"2008","unstructured":"Lippi G, Franchini M (2008) Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 34:747\u2013761","journal-title":"Semin Thromb Hemost"},{"key":"753_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1055\/s-0029-1242713","volume":"35","author":"G Lippi","year":"2009","unstructured":"Lippi G, Franchini M, Favaloro EJ (2009) Unsuspected triggers of venous thromboembolism\u2014trivial or not so trivial? Semin Thromb Hemost 35:597\u2013604","journal-title":"Semin Thromb Hemost"},{"key":"753_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11239-009-0365-8","volume":"29","author":"M Montagnana","year":"2010","unstructured":"Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G (2010) The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 29:489\u2013496","journal-title":"J Thromb Thrombolysis"},{"key":"753_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0031-1273081","volume":"37","author":"G Lippi","year":"2011","unstructured":"Lippi G, Favaloro EJ, Franchini M (2011) Coagulopathies and thrombosis: usual and unusual causes and associations, Part IV. Semin Thromb Hemost 37:175\u2013180","journal-title":"Semin Thromb Hemost"},{"key":"753_CR7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1055\/s-0031-1297363","volume":"37","author":"EJ Favaloro","year":"2011","unstructured":"Favaloro EJ, Franchini M, Lippi G (2011) Coagulopathies and thrombosis: usual and unusual causes and associations Part V. Semin Thromb Hemost 37:859\u2013862","journal-title":"Semin Thromb Hemost"},{"key":"753_CR8","unstructured":"The free dictionary. Definition of paradoxical. Available at: http:\/\/www.thefreedictionary.com\/paradoxical"},{"key":"753_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1024\/0301-1526\/a000067","volume":"40","author":"S Lehmeyer","year":"2011","unstructured":"Lehmeyer S, Lindhoff-Last E (2011) New aspects of paradoxical embolism. Vasa 40:31\u201340","journal-title":"Vasa"},{"key":"753_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","volume":"88","author":"M Makris","year":"2002","unstructured":"Makris M, Colvin B, Gupta V, Shields ML, Smith MP (2002) Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand\u2019s disease. Thromb Haemost 88:387\u2013388","journal-title":"Thromb Haemost"},{"key":"753_CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1160\/TH04-03-0148","volume":"92","author":"M Franchini","year":"2004","unstructured":"Franchini M (2004) Thrombotic complications in patient with hereditary bleeding disorders. Thromb Haemost 92:298\u2013304","journal-title":"Thromb Haemost"},{"issue":"Suppl. 2","key":"753_CR12","first-page":"S33","volume":"6","author":"M Franchini","year":"2008","unstructured":"Franchini M (2008) Surgical prophylaxis in von Willebrand\u2019s disease: a difficult balance to manage. Blood Transfus 6(Suppl. 2):S33\u2013S38","journal-title":"Blood Transfus"},{"key":"753_CR13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","volume":"99","author":"PM Mannucci","year":"2002","unstructured":"Mannucci PM, Chediak J, Hanna W, Byrnes J, Marlies L, Ewenstein BM, and the Alphanate Study Group (2002) Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99:450\u2013456","journal-title":"Blood"},{"key":"753_CR14","first-page":"1279","volume":"88","author":"M Franchini","year":"2003","unstructured":"Franchini M, Rossetti G, Tagliaferri A et al (2003) Efficacy and safety of factor VIII\/von Willebrand factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand\u2019s disease. Haematologica 88:1279\u20131283","journal-title":"Haematologica"},{"key":"753_CR15","doi-asserted-by":"crossref","unstructured":"Iorio A, Matino D, D\u2019Amico R, Makris M (2010) Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors. Cochrane Database Syst Rev (8): CD004449","DOI":"10.1002\/14651858.CD004449.pub3"},{"key":"753_CR16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1055\/s-0037-1614205","volume":"91","author":"M Franchini","year":"2004","unstructured":"Franchini M, Tagliaferri A, Rossetti G et al (2004) Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopedic surgery without antithrombotic prophylaxis. Thromb Haemost 91:1053\u20131055","journal-title":"Thromb Haemost"},{"key":"753_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-105-2-215","volume":"105","author":"RG Kopitsky","year":"1985","unstructured":"Kopitsky RG, Geltman EM (1985) Unstable angina associated with factor VIII concentrate therapy for hemophilia A. Ann Intern Med 105:215\u2013216","journal-title":"Ann Intern Med"},{"key":"753_CR18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0002-9343(92)90206-Q","volume":"93","author":"B Ritchie","year":"1992","unstructured":"Ritchie B, Woodman RC, Poon MC (1992) Deep venous thrombosis in hemophilia A. Am J Med 93:699\u2013700","journal-title":"Am J Med"},{"key":"753_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.2830500321","volume":"50","author":"B Djulbegovic","year":"1995","unstructured":"Djulbegovic B (1995) Lack of prophylactic anticoagulant therapy is not associated with clinical thrombotic complications in patients with hemophilia who undergo orthopedic surgical procedures. Am J Hematol 50:229\u2013230","journal-title":"Am J Hematol"},{"key":"753_CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2141.2001.03186.x","volume":"115","author":"GDO Lowe","year":"2001","unstructured":"Lowe GDO (2001) Factor IX and thrombosis. Br J Haematol 115:507\u2013513","journal-title":"Br J Haematol"},{"key":"753_CR21","first-page":"3","volume":"28","author":"JM Lusher","year":"1991","unstructured":"Lusher JM (1991) Thrombogenicity associated with factor IX complex concentrates. Semin Hematol 28:3\u20135","journal-title":"Semin Hematol"},{"key":"753_CR22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-0038-1642515","volume":"71","author":"E Santagostino","year":"1994","unstructured":"Santagostino E, Mannucci PM, Gringeri A et al (1994) Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Thromb Haemost 71:737\u2013740","journal-title":"Thromb Haemost"},{"key":"753_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11239-008-0253-7","volume":"28","author":"M Franchini","year":"2009","unstructured":"Franchini M, Targher G, Montagnana M, Lippi G (2009) Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary? J Thromb Thrombolysis 28:215\u2013219","journal-title":"J Thromb Thrombolysis"},{"key":"753_CR24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152\u2013155","journal-title":"Lancet"},{"key":"753_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","volume":"83","author":"RA Kraaijenhagen","year":"2000","unstructured":"Kraaijenhagen RA, Anker PS, Koopman MMW et al (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83:5\u20139","journal-title":"Thromb Haemost"},{"key":"753_CR26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","volume":"88","author":"PM Mannucci","year":"2002","unstructured":"Mannucci PM (2002) Venous thromboembolism in von Willebrand disease. Thromb Haemost 88:378\u2013379","journal-title":"Thromb Haemost"},{"key":"753_CR27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","volume":"99","author":"PM Mannucci","year":"2002","unstructured":"Mannucci PM, Chediak J, Hanna W, Byrnes J, Marlies L, Ewenstein BM, and the Alphanate Study Group (2002) Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99:450\u2013456","journal-title":"Blood"},{"key":"753_CR28","doi-asserted-by":"crossref","unstructured":"Coppola A, Franchini M, Makris M, Santagostino E, DI Minno G, Mannucci PM (2012) Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies. Haemophilia. 2012 Feb 15. [Epub ahead of print]","DOI":"10.1111\/j.1365-2516.2012.02758.x"},{"key":"753_CR29","doi-asserted-by":"crossref","unstructured":"Lippi G, Franchini M, Montagnana M, Favaloro EJ (2011) Inherited disorders of blood coagulation. Ann Med. 2011 May 17. [Epub ahead of print]","DOI":"10.3109\/07853890.2011.576698"},{"key":"753_CR30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2516.2006.01299.x","volume":"12","author":"A Girolami","year":"2006","unstructured":"Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B (2006) Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia 12:345\u2013351","journal-title":"Haemophilia"},{"key":"753_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11239-011-0578-5","volume":"32","author":"RS Woodruff","year":"2011","unstructured":"Woodruff RS, Sullenger B, Becker RC (2011) The many faces of the contact pathway and their role in thrombosis. J Thromb Thrombolysis 32:9\u201320","journal-title":"J Thromb Thrombolysis"},{"key":"753_CR32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","volume":"125","author":"E Stavrou","year":"2010","unstructured":"Stavrou E, Schmaier AH (2010) Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb Res 125:210\u2013215","journal-title":"Thromb Res"},{"key":"753_CR33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI103109","volume":"34","author":"OD Ratnoff","year":"1955","unstructured":"Ratnoff OD, Colopy JE (1955) Familial hemorrhagic trait associated with deficiency of clot-promoting fraction of plasma. J Clin Invest 34:602\u2013613","journal-title":"J Clin Invest"},{"key":"753_CR34","first-page":"328","volume":"86","author":"G Lippi","year":"2001","unstructured":"Lippi G, Franchini M, Brazzarola P, Manzato F (2001) Preoperative screening: the rationale of measuring APTT in risk assessment. Haematologica 86:328","journal-title":"Haematologica"},{"key":"753_CR35","first-page":"43","volume":"143","author":"WM Halbmayer","year":"1993","unstructured":"Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M (1993) Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction. Wien Med Wochenschr 143:43\u201350","journal-title":"Wien Med Wochenschr"},{"key":"753_CR36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/B:THRO.0000037670.42776.cd","volume":"17","author":"A Girolami","year":"2004","unstructured":"Girolami A, Randi ML, Gavasso S, Lombardi AM, Spiezia F (2004) The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis 17:139\u2013143","journal-title":"J Thromb Thrombolysis"},{"key":"753_CR37","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","volume":"108","author":"CJ Doggen","year":"2006","unstructured":"Doggen CJ, Rosendaal FR, Meijers JC (2006) Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood 108:4045\u20134051","journal-title":"Blood"},{"key":"753_CR38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2004.05.005","volume":"114","author":"MJ Gallimore","year":"2004","unstructured":"Gallimore MJ, Harris SL, Jones DW, Winter M (2004) Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res 114:91\u201396","journal-title":"Thromb Res"},{"key":"753_CR39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2007.02530.x","volume":"5","author":"G Endler","year":"2007","unstructured":"Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C (2007) Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 5:1143\u20131148","journal-title":"J Thromb Haemost"},{"key":"753_CR40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/aje\/kwq349","volume":"173","author":"CY Johnson","year":"2011","unstructured":"Johnson CY, Tuite A, Morange PE, Tregouet DA, Gagnon F (2011) The factor XII -4C\u00a0>\u00a0T variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. Am J Epidemiol 173:136\u2013144","journal-title":"Am J Epidemiol"},{"key":"753_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11239-008-0222-1","volume":"27","author":"G Lessiani","year":"2009","unstructured":"Lessiani G, Falco A, Nicolucci E, Rolandi G, Dav\u00ec G (2009) Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis 27:348\u2013351","journal-title":"J Thromb Thrombolysis"},{"key":"753_CR42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0029-1225758","volume":"35","author":"P Moerloose de","year":"2009","unstructured":"de Moerloose P, Neerman-Arbez M (2009) Congenital fibrinogen disorders. Semin Thromb Hemost 35:356\u2013366","journal-title":"Semin Thromb Hemost"},{"key":"753_CR43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1248720","volume":"36","author":"P Moerloose de","year":"2010","unstructured":"de Moerloose P, Boehlen F, Neerman-Arbez M (2010) Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 36:7\u201317","journal-title":"Semin Thromb Hemost"},{"key":"753_CR44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2516.2009.01939.x","volume":"15","author":"G Castaman","year":"2009","unstructured":"Castaman G, Lunardi M, Rigo L, Mastroeni V, Bonoldi E, Rodeghiero F (2009) Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia. Haemophilia 15:533\u2013537","journal-title":"Haemophilia"},{"key":"753_CR45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1999.01681.x","volume":"107","author":"M Lak","year":"1999","unstructured":"Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM (1999) Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 107:204\u2013206","journal-title":"Br J Haematol"},{"key":"753_CR46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MBC.0b013e3282f564fd","volume":"19","author":"I Simsek","year":"2008","unstructured":"Simsek I, de Mazancourt P, Horellou MH, Erdem H, Pay S, Dinc A, Samama MM (2008) Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes. Blood Coagul Fibrinolysis 19:247\u2013253","journal-title":"Blood Coagul Fibrinolysis"},{"key":"753_CR47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0029-1225762","volume":"35","author":"G Mariani","year":"2009","unstructured":"Mariani G, Bernardi F (2009) Factor VII deficiency. Semin Thromb Hemost 35:400\u2013406","journal-title":"Semin Thromb Hemost"},{"key":"753_CR48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.1995.tb05378.x","volume":"91","author":"M Escoffre","year":"1995","unstructured":"Escoffre M, Zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G, Dupuy E (1995) Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 91:739\u2013741","journal-title":"Br J Haematol"},{"key":"753_CR49","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1046\/j.1538-7836.2003.00395.x","volume":"1","author":"G Mariani","year":"2003","unstructured":"Mariani G, Herrmann FH, Schulman S, International Factor VII Deficiency Study Group et al (2003) Thrombosis in inherited factor VII deficiency. J Thromb Haemost 1:2153\u20132158","journal-title":"J Thromb Haemost"},{"key":"753_CR50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2516.2007.01647.x","volume":"14","author":"S Marty","year":"2008","unstructured":"Marty S, Barro C, Chatelain B et al (2008) The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia 14:564\u2013770","journal-title":"Haemophilia"},{"key":"753_CR51","doi-asserted-by":"crossref","unstructured":"Girolami A, Berti de Marinis G, Vettore S, Girolami B (2012) Congenital FVII deficiency and pulmonary embolism : a critical appraisal of all reported cases. Clin Appl Thromb Hemost. 2012 Feb 12. [Epub ahead of print]","DOI":"10.1177\/1076029611436196"},{"key":"753_CR52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11239-009-0435-y","volume":"30","author":"A Girolami","year":"2010","unstructured":"Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B (2010) Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis 30:172\u2013178","journal-title":"J Thromb Thrombolysis"},{"key":"753_CR53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, lockshin MD, Atsumi I et al (2006) International concensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"753_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13317-010-0003-7","volume":"1","author":"EJ Favaloro","year":"2010","unstructured":"Favaloro EJ, Wong RCW (2010) The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? Autoimmun Highlights 1:5\u201314","journal-title":"Autoimmun Highlights"},{"key":"753_CR55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/CCLM.2011.064","volume":"49","author":"EJ Favaloro","year":"2011","unstructured":"Favaloro EJ, Wong R (2011) Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 49:447\u2013461","journal-title":"Clin Chem Lab Med"},{"key":"753_CR56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0030-1270341","volume":"37","author":"L Heilmann","year":"2011","unstructured":"Heilmann L, Schorsch M, Hahn T, Fareed J (2011) Antiphospholipid syndrome and pre-eclampsia. Semin Thromb Hemost 37:141\u2013145","journal-title":"Semin Thromb Hemost"},{"key":"753_CR57","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","volume":"101","author":"M Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827\u20131832","journal-title":"Blood"},{"key":"753_CR58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0031-1297171","volume":"37","author":"G Kenet","year":"2011","unstructured":"Kenet G, Aronis S, Berkun Y et al (2011) Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost 37:802\u2013809","journal-title":"Semin Thromb Hemost"},{"key":"753_CR59","author":"V Pengo","year":"2012","unstructured":"Pengo V, Manzato A, Bison E, Bracco A, Denas G, Ruffatti A (2012) What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Semin Thromb Hemost. doi: 10.1055\/s-0032-1304719","journal-title":"Semin Thromb Hemost"},{"key":"753_CR60","author":"M Galli","year":"2012","unstructured":"Galli M (2012) Interpretation and recommended testing for antiphospholipid antibodies. Semin Thromb Hemost. doi: 10.1055\/s-0032-1304716","journal-title":"Semin Thromb Hemost"},{"key":"753_CR61","author":"M Franchini","year":"2012","unstructured":"Franchini M, Lippi G, Favaloro EJ (2012) Acquired inhibitors of coagulation factors: Part II. Semin Thromb Hemost. doi: 10.1055\/s-0032-1305779","journal-title":"Semin Thromb Hemost"},{"key":"753_CR62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0030-1270071","volume":"37","author":"AA Mehdi","year":"2011","unstructured":"Mehdi AA, Salti I, Uthman I (2011) Antiphospholipid syndrome: endocrinologic manifestations and organ involvement. Semin Thromb Hemost 37:49\u201357","journal-title":"Semin Thromb Hemost"},{"key":"753_CR63","author":"R Cervera","year":"2012","unstructured":"Cervera R, Espinosa G (2012) Update on the catastrophic antiphospholipid syndrome and the \u201cCAPS registry\u201d. Semin Thromb Hemost. doi: 10.1055\/s-0032-1304718","journal-title":"Semin Thromb Hemost"},{"key":"753_CR64","author":"I Les","year":"2012","unstructured":"Les I, Ruiz-Irastorza G, Khamashta MA (2012) Intensity and duration of anticoagulation therapy in the Antiphospholipid Syndrome. Semin Thromb Hemost. doi: 10.1055\/s-0032-1304720","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-012-0753-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0753-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T23:51:54Z","timestamp":1687477914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-012-0753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,29]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1007\/s11239-012-0753-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,29]]}}}